Melissa Erickson, MD, is a spine surgeon with Duke University Medical Center in Durham, N.C.
The Latest
The widespread suspension of elective surgeries due to the COVID-19 pandemic is causing significant economic difficulties for device companies and practices in the orthopedic industry.
NuVasive is reducing executive and board member compensation and taking other temporary cost-cutting measures during the COVID-19 pandemic, which has significantly lowered elective procedure volumes.
Financial relief provided under the Coronavirus Aid, Relief and Economic Security Act won't be enough to keep musculoskeletal care providers afloat after the COVID-19 crisis, the American Association of Orthopaedic Surgeons said in an April 10 letter to congressional leaders.
Johnson & Johnson subsidiary Ethicon is scrapping plans to buy Takeda Pharmaceutical's TachoSil surgical patch for controlling bleeding, Reuters reports.
Clearwater-based Florida Spine Institute and its surgery center is laying off 62 employees and suspending operations due to mounting economic difficulties caused by the COVID-19 pandemic, Tampa Bay Business Journal reports.
Leawood, Kan.-based ValueHealth, a privately-held digital healthcare partner, named Scott Martin southwest regional president on April 14.
Axis Spine received $1 million (830,000 pounds) from three investors as it readies to advance its anterior spinal implant technology in the U.S., Business Leader reports.
The FDA on April 14 granted TDi 510(k) clearance for its SonoVision ultrasound system for spine surgery.
Biotechnology company CytoDyn told investors on April 13 that five patients with mild-to-moderate COVID-19 symptoms were able to get off oxygen after taking its leronlimab drug, Proactive Investors reports.